Business · 30/11/2018Updated: 10/17/2026 · 1 min read
FDA Requests Public Comment on Proposed Clinical Investigation Monitoring Approach
The Food and Drug Administration is seeking public input on a proposed risk-based approach to monitoring clinical investigations, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →